BCAX Bicara Therapeutics Inc. - Common Stock

NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗
$20.42
价格 · 五月 20, 2026
截至...的财报数据 五月 11, 2026
52周区间
$8–$24
77% of range
分析师评级
BUY
20 analysts
目标价
$31
+54% upside
P/E (TTM)
-6.7
ROE
-33.0%
净利润率
—

BCAX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$20.42
市值
$953M
P/E (TTM)
-6.7
每股收益 (TTM)
$-2.52
营收 (TTM)
—
股息收益率
—
ROE
-33.0%
负债/权益
—
52周区间
$8 – $24

BCAX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 —
EPS $-2.52
3-point trend, +97.2%
2023-12-31 → 2025-12-31
自由现金流 $-107M
2-point trend, -43.2%
2024-12-31 → 2025-12-31
利润率 —

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？

指标
5年趋势
BCAX
同行中位数
P/E (TTM)
2-point trend, -55.3%
-6.7
—
P/B (市净率)
2-point trend, +23.1%
2.4
7.4
Price / FCF (股价/自由现金流)
2-point trend, +29.8%
-8.9
—

盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
BCAX
同行中位数
ROA
2-point trend, -60.4%
-29.3%
-47.6%
ROE
2-point trend, -142.9%
-33.0%
-62.8%
ROIC
2-point trend, -131.2%
-38.8%
—

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
BCAX
同行中位数
Current Ratio (流动比率)
2-point trend, -47.8%
14.6
5.6
Quick Ratio (速动比率)
2-point trend, -47.4%
14.3
—

成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
BCAX
同行中位数

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
BCAX
同行中位数
EPS (Diluted) (EPS (稀释))
3-point trend, +97.2%
$-2.52
—

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
BCAX
同行中位数

BCAX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

买入 20 位分析师
  • 强烈买入 6 30.0%
  • 买入 10 50.0%
  • 持有 4 20.0%
  • 卖出 0 0.0%
  • 强烈卖出 0 0.0%

12个月价格目标

13 位分析师 · 2026-05-20
中位数目标 $31.00 +51.8%
平均目标 $31.46 +54.1%

收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期

平均惊喜
-0.08%
期间 EPS Actual EPS 预期 惊喜
2026年3月31日 $-0.93 $-0.77 -0.16%
2025年12月31日 $-0.68 $-0.68 0.00%
2025年9月30日 $-0.67 $-0.56 -0.11%
2025年6月30日 $-0.50 $-0.58 0.08%
2025年3月31日 $-0.68 $-0.42 -0.26%
2024年12月31日 $-0.39 $-0.33 -0.06%

同行比较 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
BCAX $953M -6.7 — — -33.0% —
PGEN $1.48B -3.1 146.7% -2588.2% 3159.1% —
DMRA — — 38.3% -17981.1% -167.0% —
VIR $841M -1.9 -7.6% -638.9% -51.1% —
KALV $685M -3.7 — — -172.9% —
BHVN $1.50B -1.6 — — -310.8% —
AVBP $854M -4.7 — — -59.7% —
OLMA $2.03B -13.4 — — -39.4% —
MPLT $773M -0.9 — — -151.1% —

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 14
BCAX 的年度损益表数据
指标 趋势 202520242023
R&D Expense 2-point trend, +107.8% · $64M $31M
SG&A Expense 3-point trend, +229.0% $31M $19M $9M
Operating Expenses 3-point trend, +290.1% $156M $82M $40M
Operating Income 3-point trend, -290.1% $-156M $-82M $-40M
Interest Income 3-point trend, +1260.0% $18M $15M $1M
Other Non-op 3-point trend, +247.8% $18M $15M $-12M
Pretax Income 3-point trend, -165.0% $-138M $-68M $-52M
Income Tax 3-point trend, +4240.0% $217.0K $187.0K $5.0K
Net Income 3-point trend, -165.4% $-138M $-68M $-52M
EPS (Basic) 3-point trend, +97.2% $-2.52 $-4.05 $-89.61
EPS (Diluted) 3-point trend, +97.2% $-2.52 $-4.05 $-89.61
Shares (Basic) 3-point trend, +9325.3% 54,676,896,000 16,805,524,000 580,109,000
Shares (Diluted) 3-point trend, +9325.3% 54,676,896,000 16,805,524,000 580,109,000
EBITDA 2-point trend, -88.9% $-156M $-82M ·
资产负债表 19
BCAX 的年度资产负债表数据
指标 趋势 202520242023
Cash & Equivalents 3-point trend, -58.0% $97M $490M $230M
Short-term Investments 2-point trend, +318116000.00 $318M $0 ·
Prepaid Expense 3-point trend, +1045.7% $7M $13M $633.0K
Current Assets 3-point trend, +82.6% $422M $503M $231M
PP&E (Net) 3-point trend, +63.4% $330.0K $155.0K $202.0K
Other Non-current Assets 3-point trend, +230.0% $7M $7M $2M
Total Assets 3-point trend, +84.2% $431M $510M $234M
Accrued Liabilities 2-point trend, +59.9% · $13M $8M
Current Liabilities 3-point trend, +91.9% $29M $18M $15M
Capital Leases 3-point trend, +59.4% $593.0K $131.0K $372.0K
Other Non-current Liabilities 2-point trend, -100.0% · $0 $17.0K
Total Liabilities 3-point trend, +90.9% $30M $18M $15M
Common Stock 3-point trend, +250.0% $7.0K $7.0K $2.0K
Paid-in Capital 3-point trend, +17786.3% $760M $713M $4M
Retained Earnings 3-point trend, -134.6% $-359M $-221M $-153M
AOCI 2-point trend, +243000.00 $243.0K $0 ·
Stockholders' Equity 3-point trend, +369.8% $401M $492M $-149M
Liabilities + Equity 3-point trend, +84.2% $431M $510M $234M
Shares Outstanding 3-point trend, +8738.5% 56,600,724 54,440,013 640,386
现金流 10
BCAX 的年度现金流数据
指标 趋势 202520242023
Stock-based Comp 3-point trend, +690.2% $15M $7M $2M
Deferred Tax Flat — no change across 3 periods $0 $0 $0
Operating Cash Flow 3-point trend, -134.1% $-107M $-75M $-46M
CapEx 3-point trend, -52.2% $280.0K $71.0K $586.0K
Investing Cash Flow 3-point trend, -54243.5% $-318M $-9.0K $-586.0K
Stock Issued 3-point trend, +29498000.00 $29M $332M $0
Net Stock Activity 2-point trend, -91.1% $29M $332M ·
Financing Cash Flow 3-point trend, -88.2% $32M $334M $272M
Net Change in Cash 3-point trend, -273.7% $-393M $259M $226M
Free Cash Flow 2-point trend, -43.2% $-107M $-75M ·
盈利能力 3
BCAX 的年度盈利能力数据
指标 趋势 202520242023
ROA 2-point trend, -60.4% -29.3% -18.3% ·
ROE 2-point trend, -142.9% -33.0% -13.6% ·
ROIC 2-point trend, -131.2% -38.8% -16.8% ·
流动性与偿付能力 2
BCAX 的年度流动性与偿付能力数据
指标 趋势 202520242023
Current Ratio 2-point trend, -47.8% 14.6 27.9 ·
Quick Ratio 2-point trend, -47.4% 14.3 27.2 ·
每股 4
BCAX 的年度每股数据
指标 趋势 202520242023
Book Value / Share 2-point trend, -21.5% $7.09 $9.04 ·
Cash Flow / Share 2-point trend, +54.5% $-0.00 $-0.00 ·
Cash / Share 2-point trend, -81.0% $1.71 $9.00 ·
EPS (TTM) 2-point trend, +37.8% $-2.52 $-4.05 ·
估值 (TTM) 8
BCAX 的年度估值 (TTM)数据
指标 趋势 202520242023
Net Income TTM 2-point trend, -102.9% $-138M $-68M ·
Market Cap 2-point trend, +0.4% $953M $948M ·
P/E 2-point trend, -55.3% -6.7 -4.3 ·
P/B 2-point trend, +23.1% 2.4 1.9 ·
P / Tangible Book 2-point trend, +23.1% 2.4 1.9 ·
P / Cash Flow 2-point trend, +29.7% -8.9 -12.7 ·
P / FCF 2-point trend, +29.8% -8.9 -12.7 ·
Earnings Yield 2-point trend, +35.6% -15.0% -23.2% ·

财务报表 损益表、资产负债表、现金流量表 — 年度，近5年

损益表
2025-12-312024-12-312023-12-31
净收入 $-138M$-68M$-52M
稀释后每股收益 (EPS) $-2.52$-4.05$-89.61
资产负债表
2025-12-312024-12-312023-12-31
流动比率 14.627.9—
速动比率 14.327.2—
现金流
2025-12-312024-12-312023-12-31
自由现金流 $-107M$-75M—

最新新闻 提及该公司的近期头条新闻

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存，并会跟随您浏览所有股票。